XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Bison Capital Acquisition Corp., sponsored by Bison Capital, was a healthcare-focused blank-check company that completed its initial public offering in 2017. In September 2018, the SPAC announced a definitive agreement to merge with Xynomic Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company with an oncology-oriented pipeline. The transaction falls within the healthcare sector and is recorded as closed with the SEC under CIK 0001697805. The deal was part of a broader wave of SPAC activity targeting pharmaceutical development companies during that period, as sponsors sought growth-stage healthcare assets for public market access. Sign up at SpacDesk for full filing history, deal timelines, and analytics on this and thousands of other SPAC transactions.

SPAC Counterparty (1)